MELATONIN (doses of 10mg daily or less)
Clinical Indication
Sleep disorders in children with Attention Deficit Hyperactive Disorder (ADHD), autism, visual impairment, learning difficulties, developmental delay and Smith-Magenis syndrome, as outlined in LLR APC guidance. Continued in adults if proven efficacy in childhood
Comments
Yellow only applies to the products stated in the LLR APC guidance. Other formulations are secondary care only.
Date of classification
May 2015
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .